Hemogenyx Pharmaceuticals Plc (HOPHF)
OTCMKTS
· Delayed Price · Currency is USD
0.0400
-1.2000 (-96.77%)
Jun 12, 2025, 8:00 PM EDT
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of $10.75 million as of June 18, 2025. Its market cap has decreased by -57.45% in one year.
Market Cap
10.75M
Enterprise Value
14.01M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has decreased from 13.93M to 10.75M, a decrease of -22.82%. That is a compound annual growth rate of -3.31%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.60B |
Elite Pharmaceuticals | 790.52M |
Veradigm | 747.25M |
Nika Pharmaceuticals | 708.22M |
Tian'an Technology Group | 637.25M |
CytoDyn | 437.04M |
Glass House Brands | 398.13M |
Northwest Biotherapeutics | 388.59M |